Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07511179 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalized Closed-Loop Brain Stimulation for Patients With Primary Progressive Aphasia

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-10
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 2026 → Dec 2026
See other at-risk trials from Johns Hopkins University

Amendment history

2026-10-02
minor
Start date pushed: 2026-09 → 2026-10
2026-09-01
notable
Study Status v2
Primary completion pushed: 2026-08 → 2026-12
Completion pushed: 2026-08 → 2026-12
Start date2026-06→2026-09
2026-05-06
minor
Study Status v1
Primary completion pushed: 2026-07 → 2026-08
Completion pushed: 2026-07 → 2026-08
Start date2026-05→2026-06
2026-03-30
minor
Original filing
This research study investigates the feasibility and efficacy of a personalized, closed-loop electroencephalogram-transcranial electrical stimulation (EEG-tES) intervention for individuals with Primary Progressive Aphasia (PPA), addressing the inconsistent results of generic brain stimulation protocols. By integrating artificial intelligence (AI)-derived insights with real-time data, the study aims to customize transcranial electrical stimulation (tES) parameters, including electrode placement, intensity, and frequency to target the specific brain regions responsible for abnormal signaling in each participant. Over the intervention period paired with computerized cognitive training, the project will evaluate improvements in learning, memory, and functional connectivity, while simultaneously identifying clinical and physiological predictors to determine the viability of transitioning this low-cost, non-invasive technology into a remotely supervised, home-based therapy setting. The study duration will be a total of 6-8 weeks.
Trial Details
NCT Number NCT07511179
Lead Sponsor Johns Hopkins University
Collaborators: Mackler-Goding Foundation
Conditions PPA
Enrollment 10 participants
Start Date 2026-10
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-10-01